Active, not recruitingPhase 2NCT06679985
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Studying Pediatric hepatocellular carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Coherus Oncology, Inc.
- Intervention
- Casdozokitug(drug)
- Enrollment
- 72 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (30)
- Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
- University of Arizona - Cancer Center, Tucson, Arizona, United States
- Beverly Hills Cancer Center, Beverly Hills, California, United States
- City of Hope, Duarte, California, United States
- City of Hope at Irvine Lennar, Irvine, California, United States
- Cancer & Blood Specialty Clinic, Lakewood, California, United States
- USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Sarcoma Oncology Center, Santa Monica, California, United States
- Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
- The Winship Cancer Institute Emory University, Atlanta, Georgia, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center, Boise, Idaho, United States
- University of Kansas Cancer Center, Kansas City, Kansas, United States
- UofL Health Brown Cancer Center, Louisville, Kentucky, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- Christus St. Vincent Regional Medical Center, Santa Fe, New Mexico, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06679985 on ClinicalTrials.govOther trials for Pediatric hepatocellular carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07328009A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular CarcinomaFudan University
- RECRUITINGNCT07295340Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC DetectionWest China Hospital
- RECRUITINGPHASE1NCT07364357A Phase I Study of CREPT-618 in Locally Advanced HCCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGPHASE4NCT06717919HOPE Against Cancer Recurrence in HCCPhilipp Dutkowski
- RECRUITINGNCT07173868FDG PET-CT in Advanced Breast CancerSamsung Medical Center
- RECRUITINGNANCT06899152HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerMontefiore Medical Center
- RECRUITINGPHASE1, PHASE2NCT07053488CRISPR-Edited HLA Donor Liver Transplant to Reduce RejectionAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
- RECRUITINGNANCT06934018Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal CancerFudan University